DEEPVESSEL FFR is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CCTA). The software processes coronary CTA images semi-automatically, generates a three-dimensional model of the coronary artery tree, and estimates CT FFR values. DEEPVESSEL FFR is FDA-Cleared, CE-Marked, NMPA-Cleared, HSA-Certified.

Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers in Beijing, Shanghai, Shenzhen, and Seattle. 

The deep-learning-based CT FFR analysis DEEPVESSEL FFR is the company's flagship product. The AI CT FFR is FDA-cleared, CE-marked, and NMPA-approved. DEEPVESSEL FFR is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CCTA). 

Direct is the leading EHR-integrated cost transparency solution. The solution brings real-time, pharmacy benefit cost information, coverage restrictions, and alternatives into native EHR workflows. Giving providers cost information at the point-of-care enables data-driven and evidence-based decisions that help patients get the care they need at prices they can afford.

Features and Benefits:

 - Access to lower-cost alternatives increases care adherence and patient health and satisfaction

 - Select medications that do not require prior authorization

 - Reduced pharmacy/PBM/payer call-backs, prior authorization denials, and other uncompensated provider hassles

 - Uses native order workflows, is easy to implement

- Surfaces pharmacy alternatives to drive continuity of care and patient satisfaction

- Integrates patient affordability program offerings into RTPB results, showing best-cost options when insurance coverage isn't found or doesn't apply. 

Arrive Health is a healthcare technology company dedicated to putting the needs of patients and providers first. We improve access to the most affordable, quality care by delivering accurate, patient-specific cost and coverage data to providers, care teams, and patients. Collaborating with premier health systems, pharmacy benefit managers, payers, and healthcare IT vendors, Arrive Health is clearing the way for better health by reducing friction in care workflows and enabling meaningful conversations about access to care. To learn more, please visit ArriveHealth.com.

Deep Learning

Accurate

Fast

Comprehensive

Flexible Payment Model

Accessible

Deep Learning

Accurate

Fast

Comprehensive

Flexible Payment Model

Accessible

Our solution is seamlessly embedded into EHR workflows, allowing for direct connections to payer and PBM source-of-truth data. EHRs typically allow for one or many connections to Real-Time Prescription Benefit solutions, but rarely have their own prescription price transparency capabilities built-in. 

Arrive Health delivers the industry's most accurate, patient-specific cost and coverage information to the EHR. Many providers do not trust the pricing information displayed in their workflow because of its obsolete or incorrect nature (see whitepaper below). However, Arrive Health delivers data that providers can rely on, taking into consideration up-to-date copay and deductible information, benefit details, and preferred locations. We also display therapeutic alternatives that are covered under the patient's insurance, options that might not require prior authorization, and options at a health system's own internal pharmacy.